HONG KONG—Ogilvy Public Relations Worldwide has agreed to acquire a majority stake in the Hong Kong-based healthcare communications firm Mind Resource Healthcare Consulting as part of an effort to target the Hong Kong healthcare industry and further extend its market position in Hong Kong.
The acquisition will help Ogilvy increase its capabilities in serving the pharmaceuticals, healthcare services and medical devices market, valued at HK$95 billion (US$12.1 billion), according to Business Monitor International.
Founded in 2007, Mind Resource services include disease awareness, patient education, and medical education campaigns. Janet Yeung, founder, will retain a minority interest in the company following completion of the transaction and continue to serve as general manager Mind Resource will become the Hong Kong arm of Ogilvy’s global integrated healthcare communications service group OgilvyHealth.
“Many global pharmaceutical brands are turning to Asia for growth opportunities,” says Steve Dahllof, -president and CEO, Asia Pacific for Ogilvy Public Relations Worldwide. “Now more than ever, they need partners who have a deep understanding of the local regulatory environment and market nuances.”
The clients of the combined agency include Alcon, Bayer, Boehringer Ingelheim, Eli Lilly, Glaxo Smithkline, Invisalign, Janssen, MSD, Novartis, Pfizer, Roche, among others.